Wuhan Sairui Biomedical Technology Co., Ltd.

Wuhan Sairui Biomedical Technology Co., Ltd. was established in 2021 and is located in the Optics Valley Precision Medicine Industrial Base in Wuhan East Lake High-tech Development Zone, focusing on technology development and services in the biomedical field. The company's core business covers stem cell technology development, gene diagnosis and treatment research, pharmaceutical testing instrument sales, and transformation of scientific research achievements, focusing on technological innovation and industrial application in frontier directions such as oncology and molecular biology. Relying on the advantages of the Optics Valley biomedical industry cluster, the company has built a complete service system from basic research to technology implementation, equipped with specialized experimental platforms such as cell culture and animal experiments. The team brings together a number of researchers with academic backgrounds in the oncology field, and core members have participated in multiple * research projects and published research results in internationally authoritative journals such as Science and Nature. The company is committed to providing precision medicine solutions for medical institutions and research institutes, and has cumulatively provided technical support for more than ten top-tier hospitals and university laboratories in China. The company upholds the concept of "innovation-driven development," continuously improves its scientific research management system, and emphasizes employee career growth and teamwork. Through standardized five insurances and one housing fund, academic exchange support, and annual domestic and international team-building activities, it creates a sustainable development platform for technical talent. In the future, it will continue to deepen its work in the biotechnology field and expand application scenarios in emerging directions such as gene editing and cell therapy.